CPGShield resources · Print artwork requirements
Beauty packaging creates a predictable conflict.
Marketing wants white space.
Design wants elegance.
Legal needs more copy.
Then someone asks:
“How small can we make the text?”
There is no single universal FDA font size for every word on a cosmetic package.
Different required statements can have different rules.
Some are tied to fixed minimum letter heights.
Some depend on the size of the principal display panel.
Others must simply be reasonably related to surrounding text and sufficiently prominent.
That means “use at least 6-point font” is not a reliable cosmetic-label rule.
FDA's Cosmetic Labeling Guide states that the ingredient declaration generally must appear in letters at least 1/16 inch in height.
For packages with less than 12 square inches of total surface area available to bear labeling, the regulation allows ingredient lettering as small as 1/32 inch under the applicable conditions.
That is a physical measurement.
It is not the same thing as a point-size setting in Illustrator, InDesign, Canva, or another design tool.
Font geometry varies.
A nominal point size does not necessarily tell you the actual height of the regulated letter.
For certain cosmetic labeling measurements, FDA's guide explains that letter height is based on the height of the lowercase “o”, or an equivalent letter when upper- and lowercase letters are used.
This is the sort of detail that rarely appears in a brand's marketing brief.
It matters when the artwork is being squeezed into a small panel.
A designer may say:
“It is still technically six-point text.”
The regulatory question may be:
“What is the actual printed letter height?”
Those are different questions.
The net quantity statement has a separate scale.
FDA's guide summarizes minimum letter heights based on the area of the principal display panel:
So making the package larger can actually increase the required minimum size of the quantity statement.
That is counterintuitive.
A brand can enlarge its packaging, keep the old artwork proportions, and accidentally leave the net quantity statement too small for the new panel.
FDA's Cosmetic Labeling Guide states that warning statements generally may be no smaller than 1/16 inch, unless another regulation establishes a different size.
Warnings also must be prominent and conspicuous.
FDA describes the lettering as bold type on a contrasting background.
So “technically present” is not enough.
If the warning disappears into metallic foil, decorative texture, low contrast, or crowded copy, the label can still have a presentation problem.
The identity statement-what the product actually is-does not follow the same fixed scale as the ingredient declaration.
FDA's guide says the statement of identity must be in bold type and in a size reasonably related to the most prominent printed matter on the principal display panel.
That typically means the brand cannot make the product identity microscopic while allowing a fanciful product name to dominate the package.
Consumers still need to understand what they are buying.
Design software typically works in points.
Regulations often work in inches of actual printed letter height.
A point is a typographic unit, but two fonts at the same point size can have different lowercase-letter heights.
Then printing introduces more variables:
The correct time to measure the artwork is therefore after the final layout exists at its intended physical dimensions.
A screenshot does not reliably preserve physical scale.
Neither does a random photograph of a bottle.
A camera introduces:
That is why precise label measurement should be tied to a print-ready file when possible. The artwork review explains what CPGShield measures from a PDF.
A PDF with known dimensions is much more suitable for checking measurable artwork properties.
A final cosmetic artwork review should check more than text content.
It should ask:
A label can contain every correct sentence and still fail one of those questions.
FDA generally requires ingredient declarations to use letters at least 1/16 inch high, with a 1/32-inch provision for certain packages with less than 12 square inches of available labeling surface.
No. The rules are expressed in physical letter measurements and other presentation standards, not one universal point size.
It depends on the area of the principal display panel. FDA's required minimum letter height increases as PDP area increases.
FDA's labeling guide states that warning statements generally may not be less than 1/16 inch unless a specific regulation allows another size.
A photo can support visual review but may not provide reliable physical scale for precise type-size measurement.
That gap is why CPGShield's artwork checks matter.
Bring measurable print-artwork checks into your label review. CPGShield checks supported PDF properties such as type size, boldness, contrast, and panel placement, with findings to guide the next revision.
Review the final file before printing, then share the findings with your designer.
→ Upload your print-ready cosmetic label to CPGShield
A text scan is free. Measuring supported print-ready PDFs costs one check credit; supported PDF corrections cost one additional check credit. Unsupported or unreadable artwork checks remain unverified and require review before printing.
Run the scan before you approve the print order.
This article is educational and does not constitute legal advice.
Free cosmetic label compliance check. No demo required, no card. CPGShield LLC provides independent screening. We are not affiliated with, endorsed by, or acting for any retailer, brand, agency or organization we name.